Jones Lab

Our research spans two primary domains; improving understanding of the heritable risk for cancer, and mapping changes in the tumor genome through cancer progression to understand the mechanisms that underlie chemo-resistance and relapse. We use new genomics technologies, apply gold standard bioinformatics methods and perform multi-omic analyses to discover how genetic variation impacts disease risk, initiation and progression. We generate our own genomic data sets in the lab and complement them by collaborating with large consortiums and biobank studies to perform multi-cohort and population scale analysis.